Introduction
Obesity is a multifactorial disease resulting from the interactions between susceptibility genes and environmental factors. The obesity gene map 1 reveals that putative loci affecting obesity-related phenotypes are found on all autosomes and on chromosome Y. The number of genes, markers and chromosomal regions that have been thus far associated or linked with obesity phenotypes is increasing and reach now about 200. Some obesity cases have been shown in humans to result from single gene mutations. The genes involved are: leptin receptor (LEPR 2 ), proopiomelanocortin (POMC 3 ), prohormone convertase 1 (PCSK1 4 ), leptin (LEP 5 ± 7 ), and melanocortin 4 receptors (MC4R 8 ± 10 ). The aim of the research was to identify some of the genes expressed in adipose tissue of obese individuals, which could potentially be related to the regulation of the body mass and to the pathogenesis of obesity. The identi®cation of such genes may provide new candidates for ongoing and future studies.
Our approach was to use subtractive hybridization technique. Numerous subtractive approaches have been developed, including differential display, 11 representational difference analysis, 12 suppression subtractive hybridization (SSH 13, 14 ) and others. Applications of SSH to obesity have not been reported yet, but SSH has been used successfully to identify differentially expressed genes in the mdx mouse model of Duchenne muscular dystrophy, 15 to clone genes responsible for one of the retinis pigmentosa diseases, human umbilical arterial endothelial cells, 17 and for the analysis of immune system gene expression in small rheumatoid arthritis biopsies. 18 The technique combines subtractive hybridization with PCR to generate a population of PCR fragments enriched for differentially expressed genes. The method typically yields a variety of cDNA molecules that are differentially expressed in a given tissue and for a de®ned physiological state. It is well established that, at the molecular level, many genes involved in lipid metabolism, glucose homeostasis and other pathways are preferentially expressed in fat depots. 19, 20 We contrasted, by SSH, the level of expression of genes in abdominal subcutaneous fat between obese (body mass index, BMI b 37 kgam 2 ) and normal-weight (BMI`25 kgam 2 ) women. We identi®ed a gene not described yet, which showed a higher expression in obese subjects.
Methods

Subjects
Written consent was obtained from each subject and experiments were conducted according to the Declaration of Helsinki. Subcutaneous abdominal adipose tissue was obtained by direct sampling from ®ve massively obese (BMI ranging from 37 to 48 kgam 2 ) women who were undergoing gastro-intestinal bypass surgery. A needle biopsy technique was used to obtain subcutaneous adipose tissue from the same depot in ®ve normal weight (BMI from 20 to 24 kgam 2 ) women.
RNA isolation
Samples of frozen (780 C) subcutaneous fat (100 mg) were broken using a tissue grind pestle in 400 ml of extraction buffer, and polyA mRNA was directly isolated on corresponding columns (QuickPrep 1 Micro mRNA Puri®cation Kit from Pharmacia Biotech). Total RNA was extracted using TriReagen 1 , BCP and Formazol 1 solutions as recommended by the manufacturer (Molecular Research Center Inc.) SSH SSH was performed using PCR-Select TM cDNA Subtraction Kit (Clontech). Pools of polyA mRNA of obese subjects (5 mg) and of normal-weight subjects (5 mg) were used for the cDNA production. SSH experiments were made in excess of cDNA of normal-weight subjects, yielding transcripts speci®c to obese subjects. PCR steps were realized with the Advantage Polymerase Mix from the same company. PCR products generated were digested by the restriction enzyme Rsal and cloned into pBluescript vector. Ligation products were used to transform One Shot TM INVaF H Competent Cells (Invitrogen).
Differential expression
Con®rmation of differential expression was made by RT-PCR. Reverse transcriptions were performed using the FirstStrand cDNA Synthesis Kit (Pharmacia Biochem). Samples of 50 ng of polyA mRNA were used as template in RT-PCR experiments. Two pairs of oligonucleotides were used: primers pair 1476 and 1477 (see Figure 1 ) and primers pair Figure 1) , and with the provided control primers pair G3PDH, generating fragments of 320 and 943 bp, respectively. The panel contains cDNA from brain, heart, kidney, liver, lung, muscle, pancreas and placenta. RT-PCR were also performed from 50 ng of polyA mRNA extracted from human adipose tissue. Reaction parameters were 30 s at 94 C, for 38 cycles of 30 s at 94 C and 2 min at 68 C, and a ®nal elongation step of 2 min at 68 C. Five microliters of the 50 ml reaction were taken after 22, 26, 30, 34 and 38 cycles, and loaded on a 2% agarose gel.
Mapping of Adipogene
The GeneBridge 4 radiation-hybrid-mapping panel 22 was screened twice using the primers GSP1 and GSP2 (see Figure 1 ). The ampli®ed region was placed relative to STSs in the Whitehead Institute for Biomedical ResearchaMIT Center for Genome Research radiation-hybrid map of the human genome by means of the RHMAPPER server (http:aawww-genome.wi.mit.eduabinacontigarhmapper.pl).
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Results
Subjects Table 1 presents characteristics of each subject. The mean age and BMI at time of sampling were 40 y and 22 kgam 2 for the normal-weight individuals, and 40 y and 42 kgam 2 for the obese patients. None of the subjects were diabetic. Fat biopsies were taken under fasting conditions.
Identi®cation of the cDNA
At the end of the SSH procedure, 79 PCR products were cloned in pBluescript. Southern blot analysis performed among clones showed that they belong to ®ve main families of DNA fragments. One clone of each family was partially sequenced and analyzed for homology in the GenBank and EMBL databases. Three families of clones were not retained at this stage because of their homology with ribosomal RNA sequences. Two clones were further investigated, the result of the ®rst one is reported here. The cDNA of 1500 base pairs long contained a potential open reading frame of 334 amino acids, generating a predicted protein of 36.3 kDa (Figure 1 ). This sequence was around 64% GC rich.
Search in databanks revealed no homology with known DNA sequence, and weak homologies at the amino acids level with members of the prokaryotic AraCaXylS family of regulators.
The homology with the consensus for the family (A---S--L--F---G----R--A--L----laV--laV---GFaY---F---
FRaK---G Ð P, whereÐis any amino acid) 24 was between amino acid 120 and 150 of the sequence (Figure 1) . No homology was detected with the human genome sequences reported recently at the National Center for Biotechnology Information NCBI (http:aawww.ncbi.nlm.nih.gova).
Differential expression
The differential expression of the new gene was con®rmed by RT-PCR experiments. We performed co-ampli®cation of a portion of this clone (1.3 kb) and of the beta-actin gene as control (Figure 2 ). The new gene was expressed at a higher level among the obese than in normal-weight subjects, except for one normal-weight individual (N1, Figure 2 ), which exhibited a signal comparable to those of the obese subjects.
Tissue distribution
The expression pattern of the gene was determined by RT-PCR analysis of mRNA from adipose and other tissues (Figure 3) . The new gene and the control gene G3PDH were ampli®ed and PCR products were analyzed after 22, 26, 30, 34 and 38 cycles of PCR. Whereas G3PDH was equally ampli®ed in all tissues, the new gene showed a strong signal in adipose tissue only. It was also expressed at a very low level (low signal at 38 cycles) in other tissues such as brain, heart, kidney, liver and muscle. No signal was detected in lung, pancreas and placenta. This pattern of tissue expression has led us to name this gene`Adipogene'.
Chromosomal location of Adipogene
According to the GeneBridge 4 Radiation Hybrid Panel, Adipogene is located on chromosome 8 at 41.575 cM from the telomere. More precisely, Adipogene is located 3.15 centiRay (cR) centromeric to AFMB057WG5 and 8 cR telomeric to WI-5767. Comparison of the Whitehead RH map with the cytogenetic map of the chromosome 8 suggests that these markers belong to the 8p12 ± 11.1 band. We estimated that the gene is located around 10 cR telomeric and less than 1 cM from the b3 adrenergic receptor (ADRB3) gene. According to the genetic location database LDB map (http:aacedar.genetics.soton.ac.ukapublic_htmlaldb.html), ADRB3 is located at 41.643 cM on chromosome 8. Three microsatellite markers, D8S1477, D8S283 and D8S268, located respectively at 34.878, 35.167 and 47.116 cM have shown, in the Que Âbec Family Study (QFS) cohort, weak linkages with BMI (0.03 P 0.04), (YC Chagnon, unpublished data), whereas the Trp64Arg ADRB3 polymorphism showed no linkage (P b 0.05). A new gene related to human obesity M Larose et al
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Discussion
The technique of SSH had led us to identify what we believe is a new candidate gene of human obesity. This gene, called Adipogene, was expressed at a higher level in obese than in normal-weight subjects, and obese individuals showed different levels of expression whereas normal-weight subjects, except one, presented the same low expression level. The expression of Adipogene was relatively weak since no signal was seen on Northern Blot with total RNA, being detected in RT-PCR experiments only. One normal-weight subject ( Figure 2 , subject N1) showed a signi®cant expression of Adipogene, similar to those of obese subjects. These observations were not observed by chance only, since a w 2 Fischer's exact test (two-tail), where the ®ve obese subjects were classi®ed as showing a positive Adipogene expression, and four out of the ®ve normal-weight subjects as showing a negative expression (Figure 2 ), gave a P-value of 0.048. A possible explanation of the difference in expression could be that Adipogene is regulated according to physiological states, for example to nutritional conditions. Actually, adipose tissue sampling was done in a con®rmed fasted state for all obese subjects, as it was obtained prior to surgical intervention, whereas normal-weight controls were requested to be in a fasted state. Obesity is a complex trait, involving the interaction of many genes and environmental factors. Any number of factors, including nutritional status, could explain the higher expression of Adipogene in subject N1. Further studies on animal models and humans are needed to clarify the effects of different nutritional conditions on Adipogene expression.
A search in databanks revealed a weak homology between Adipogene and members of the AraCaXylS family of regulators. These proteins are transcriptional regulators found in prokaryotes only, 24 and Adipogene could be a new eukaryotic protein containing this motif. The AraCaXylS proteins are involved in carbon metabolism and stress response. Further investigations are needed to determine the function of Adipogene.
Adipogene has been mapped to the chromosome 8, in a chromosomal region where previous linkages 25, 26 and associations 27 with obesity phenotypes have been reported. ADRB3, which is at the origin of most of these studies, has been considered a candidate gene for obesity for a while, because of its potential role in energy expenditure. However, the evidence of linkage between the common tryptophan to arginine (Trp64Arg) mutation in ADRB3 and obesity or BMI is weak and controversial. 28 A recent study in MexicanAmerican families suggested that ADRB3 remained a valid candidate gene for obesity even though evidence for an effect of the Trp64Arg polymorphism could not be established. 25 But it was also suggested that a gene closely linked to ADRB3 could be at the origin of the observed result. A new gene related to human obesity M Larose et al
Adipogene is located less than 1 cM from ADRB3, and could eventually be responsible for some of the linkages and associations observed in this region. The weak linkages with BMI observed in QFS with markers located in this region, but not with the Trp64Arg ADRB3 polymorphism, support this interpretation. The screening for polymorphisms within Adipogene and its promoter region, and their use in morbidly obese and QFS subjects should better allow the de®nition of the potential role of Adipogene in human obesity.
In conclusion, we have used the SSH technique to clone a novel gene named Adipogene, which is characterized by RNA expression mainly in adipose tissue, and expressed at a higher level in obese than in normal-weight subjects. Further characterization of Adipogene including protein expression using an antibody, intra-cellular localization and transgenesis overexpression is underway. A second gene evidenced with this technique is also presently under investigation. The identi®cation of these potentially new susceptibility genes can lead to a better understanding of the biology of the adipose tissue in the obese state and may provide new targets for the development of prevention and therapeutic strategies.
